SCHEMBL6122203

SCHEMBL6122203

CCOC(=O)C(C)CC(Cc1ccc(-c2ccccc2)cc1)NC(=O)c1cc(F)c(O)c(F)c1

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 14/20 0.56
▸ MMEL1 Q495T6 5/20 0.56
▸ ACE P12821 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2707455 1.00 MME (0.56) MMEMMEL1ACE
SCHEMBL2707412 0.90 MME (0.54) MMEMMEL1ACE
SCHEMBL18672735 0.90 MME (0.54) MMEMMEL1ACE
SCHEMBL18672691 0.89 MME (0.70) MMEMMEL1ACE
SCHEMBL2705953 0.89 MME (0.70) MMEMMEL1ACE
SCHEMBL12317398 0.85 MME (0.50) MMEMMEL1ACE
SCHEMBL18672729 0.85 MME (0.50) MMEMMEL1ACE
SCHEMBL2705976 0.84 MME (0.79) MMEMMEL1ACE
SCHEMBL18672713 0.83 MME (0.56) MMEMMEL1ACE
SCHEMBL12317396 0.83 MME (0.56) MMEMMEL1ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2640375-A1 METHOD OF TREATING CONTRAST-INDUCED NEPHROPATHY Novartis AG (CH) 2013-09-25 — — EP disclosed
WO-2012065958-A1 METHOD OF TREATING CONTRAST-INDUCED NEPHROPATHY NOVARTIS AG (CH) 2012-05-24 — — WO disclosed
Send feedback